Q301--VISN 19 Gene Expression Oncology Testing

Closed Pre-Solicitation Posted

Solicitation number
36C25926Q0076
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories
Place of performance
Department of Veterans Affairs Visn 19 Pathology and Laboratory, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 19 (VISN 19) is seeking qualified sources to provide oncology gene expression reference laboratory testing services, including specimen preparation, transportation, analytical testing, performance, result reporting, and consultative services. This is a sources sought notice issued for market research purposes in accordance with Federal Acquisition Regulation Part 10, not a formal request for proposal. The VA is seeking to identify Service-Disabled Veteran-Owned Small Businesses (SDVOSB), Veteran-Owned Small Businesses (VOSB), small or emerging small businesses, and large businesses capable of fulfilling the requirement. Contractors must be approved to provide clinical diagnostic laboratory tests under both Medicare and Medicaid regulations and comply with all applicable federal and state laws. The specific gene expression tests required include Oncotype DX Breast Recurrence Score Assay, Oncotype DX Breast DCIS Score Assay, Oncotype DX Colon Recurrence Score Assay, Oncoguard Liver CPT, OncoExtra, and Cologuard CPT, or equivalent alternatives. Interested firms must submit responses electronically by November 12, 2025, at 10:00 AM Mountain Time.

This procurement is not subject to any small business set-aside designations. The notice does not identify any incumbent contractors or current service providers, nor does it disclose a specific contract award value or budget range. The services will be provided to four VA Medical Centers located in Aurora, Colorado; Fort Harrison, Montana; Oklahoma City, Oklahoma; and Salt Lake City, Utah. The procurement is classified under NAICS code 621511 (Medical Laboratories) and PSC category Q301 (Reference Laboratory Testing). While no timeline for contract performance is specified in the sources sought notice, respondents should anticipate that a formal solicitation may follow once the market research phase concludes and the VA determines the number of qualified vendors available to meet this requirement.

Notice text

THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS IS NOT A REQUEST FOR PROPOSAL. The Department of Veterans Affairs, VHA, Network Contracting Office (NCO) 19 Rocky Mountain Acquisition Center is seeking potential sources that are capable of providing Oncotype Genetic (Gene Expression) Reference Lab Testing Services that includes but is not limited to: specimen preparation and storage; transportation of clinical laboratory specimens; performance of analytical testing; reporting of analytical test results; and consultative services. The Contractor shall be approved to provide clinical diagnostic laboratory tests under both Medicare and Medicaid regulations and all applicable federal and state laws.

The Contractor shall be capable of providing the following gene expression tests (OR EQUIVALENT):

a) Oncotype DX Breast Recurrence Score Assay (81519); b) Oncotype DX Breast DCIS Score Assay (0045U); c) Oncotype DX Colon Recurrence Score Assay (81525): d) Oncoguard Liver CPT (81599);

e) OncoExtra (0329U); and f) Cologuard CPT (81528)

This requirement is for the following VA Medical Centers:

Rocky Mountain Regional VA Medical Center, 1700 N. Wheeling St, Aurora, CO, 80045

VA Montana Health Care System, 3687 Veterans Dr., Fort Harrison, MT 59636

Oklahoma City VA Health Care System, 921 NE 13th St, Oklahoma City, OK, 74104

Salt Lake City VA Health Care System, 500 Foothill Drive, Salt Lake City, Ut 84148

NCO 19 is performing market research to determine if there is a sufficient number of qualified (1) Service-Disabled Veteran-Owned Small Business (SDVOSB); (2) Veteran-Owned Small Business (VOSB); (3) Small or emerging small business firms; or (4) Large businesses who can fulfill the requirement. This Sources Sought notice is issued for the purpose of market research in accordance with Federal Acquisition Regulation (FAR) Part 10. All SDVOSB, VOSB, small and large businesses capable of fulfilling the requirement are invited to respond. Any information submitted by respondents to this sources sought synopsis is voluntary. This sources sought notice is not to be construed as a commitment by the Government, nor will the Government reimburse any costs associated with the submission of information in response to this notice. Respondents will not individually be notified of the results of any Government assessments.

Responses and questions may be submitted electronically to:

Juanita.Street@va.gov and NCO19Lab@va.gov a Microsoft word compatible format no later than Wednesday, November 12th at 10:00am Mountain Time. PHONE CALLS NOT ACCEPTED.

NAICS code to be used for this acquisition is 621511. All interested firms who can MEET and FULFILL the requirements stated in the Summary of Requirements below should respond, in writing, with the following information:

Company Name:

Address:

UEI (Unique Entity ID) Number:

Contact Name:

Phone No.:

Email:

Business Size Information - Select all that applies:

Small Business

Emerging Small Business

Small Disadvantaged Business

Certified under Section 8(a) of the Small Business Act

HUBZone

Woman Owned

Certified Service-Disabled Veteran Owned Small

Veteran Owned Small Business

Large Business

Is your Company a FSS/GSA Contract Holder:

Yes No

Enter your Company s FSS/GSA Contract Number:

Enter the Effective Date/ Expiration Date of FSS/GSA Contract:

Are the proposed Genetic Oncology testing services listed and available on the above FSS/GSA Contract:

Yes No

Questions for Small Businesses ONLY:

Limitations on Subcontracting (FAR 52.219-14) What percentage of the work would be

subcontracted to another company? ________ If > 0, what is company s business size: __________

If subcontracting, what added value do you offer (FAR 52.215-23): _______________________________

Offerors capable of providing the Gene Expression Oncology tests or equivalent tests, please complete the table above and send your responses via email to Juanita.Street@va.gov and NCO19Lab@va.gov in a Microsoft word compatible format no later than Wednesday, November 12th, 10:00am Mountain Time. PHONE CALLS NOT ACCEPTED.

Files

File Type Posted
36C25926Q0076.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Q301--Reference Laboratory Testing Department of Veterans Affairs Multiple VA Medical Centers, United States · NAICS 621511 Veterans Integrated Service Network 2 No set-aside
6550--Cepheid GeneXpert Testing Supplies Beckley Vamc Clarksburg Vamc Vamhcs Washington Vamc · NAICS 325413 Veterans Integrated Service Network 5 No set-aside
Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC Seattle, Washington 98108, United States · NAICS 325413 Veterans Integrated Service Network 20 No set-aside
Emergent reference lab testing Charleston, South Carolina 29401, United States · NAICS 621511 Veterans Integrated Service Network 7 No set-aside
RFP-797-FSS-04-0001-R3: 621II Medical Laboratory Testing & Analysis Services NAICS 621511 Veterans Integrated Service Network 12 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity